Speech recognition and transcription technology developer MedQuist Holdings is changing the company's name to M*Modal, and will use the new branding for its speech and language understanding, coding, and medical transcription technologies.
The move is designed to support the company's plans to expand its core transcription business, open new markets, increase its sales force and development resources, and leverage its intellectual property portfolio, MedQuist said. Shares of the company's common stock will begin trading on the Nasdaq market under the symbol MODL on January 25.
MedQuist Holdings acquired speech recognition firm M*Modal last year for $130 million.
